Foreign-Trade Zone (FTZ) 27-Boston, Massachusetts, Notification of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (Shingles and Flu Vaccines), Andover, Massachusetts, 56928 [2022-20048]

Download as PDF 56928 Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is October 26, 2022. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Diane Finver at Diane.Finver@trade.gov. the FTZ Act and the FTZ Board’s regulations, including section 400.14. Dated: September 12, 2022. Christopher Kemp, Acting Executive Secretary. [FR Doc. 2022–20012 Filed 9–15–22; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Dated: September 12, 2022. Christopher Kemp, Acting Executive Secretary. Foreign-Trade Zones Board [B–43–2022] khammond on DSKJM1Z7X2PROD with NOTICES [FR Doc. 2022–20048 Filed 9–15–22; 8:45 am] Foreign-Trade Zone (FTZ) 27—Boston, Massachusetts, Notification of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (Shingles and Flu Vaccines), Andover, Massachusetts BILLING CODE 3510–DS–P Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Andover, Massachusetts within Subzone 27R. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on September 8, 2022. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/ component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished product(s) and material(s)/component(s) would be added to the production authority that the Board previously approved for the operation, as reflected on the Board’s website. The proposed finished products include mRNA Varicella-Zoster Virus Shingles Vaccine and saRNA Flu Vaccine (duty-free). The proposed foreign-status material/ component is N1-MethylPseudouridine-5′-Triphosphate (duty rate, 6.5%). The request indicates that the material/component is subject to duties under Section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be [B–21–2022] VerDate Sep<11>2014 16:43 Sep 15, 2022 Jkt 256001 DEPARTMENT OF COMMERCE Foreign-Trade Zone (FTZ) 18—San Jose, California, Authorization of Production Activity Epoch International Enterprises, Inc. (Printed Circuit Board Assemblies and Enclosures), Fremont, California On May 16, 2022, Epoch International Enterprises, Inc., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 18M, in Fremont, California. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (87 FR 32120, May 27, 2022). On September 13, 2022, the applicant was notified of the FTZ Board’s decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board’s regulations, including section 400.14. Dated: September 13, 2022. Christopher Kemp, Acting Executive Secretary. [FR Doc. 2022–20114 Filed 9–15–22; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration Evaluation of State Coastal Management Program; Public Meeting; Request for Comments; Correction Office for Coastal Management, National Ocean Service, National PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 Notice of public meeting and opportunity to comment; correction. ACTION: The National Oceanic and Atmospheric Administration (NOAA), Office for Coastal Management, published a document in the Federal Register of August 5, 2022, concerning a notice of public meeting to solicit comments on the performance evaluation of the Connecticut Coastal Management Program. The document contained incorrect dates. SUMMARY: FOR FURTHER INFORMATION CONTACT: Ralph Cantral, Evaluator, NOAA Office for Coastal Management, by email at Ralph.Cantral@noaa.gov or by phone at (843) 474–1357. Foreign-Trade Zones Board AGENCY: Oceanic and Atmospheric Administration, Department of Commerce. SUPPLEMENTARY INFORMATION: Correction: In the Federal Register of August 5, 2022, 87 FR 47984, correct the DATES caption to read: NOAA will consider all written comments received by Friday, October 7, 2022. A virtual public meeting will be held on Wednesday, September 28, 2022, at 6:30 p.m. Eastern Time (ET). DATES: Correction: In the Federal Register of August 5, 2022, 87 FR 47984, correct the ‘‘Public Meeting’’ caption to read: Public Meeting: Provide oral comments during the public meeting on Wednesday, September 28, 2022, at 6:30 p.m. ET at the Meigs Point Nature Center meeting room at Hammonasset Beach State Park, 1288 Boston Point Road, Madison, Connecticut 06443. Written comments received are considered part of the public record, and the entirety of the comment, including the email address, attachments, and other supporting materials, will be publicly accessible. Sensitive personal information, such as account numbers, Social Security numbers, or names of individuals, should not be included with the comment. Comments that are not responsive or that contain profanity, vulgarity, threats, or other inappropriate language will not be considered. Keelin Kuipers, Deputy Director, Office for Coastal Management, National Ocean Service, National Oceanic and Atmospheric Administration. [FR Doc. 2022–20081 Filed 9–15–22; 8:45 am] BILLING CODE 3510–JE–P E:\FR\FM\16SEN1.SGM 16SEN1

Agencies

[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Page 56928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20048]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-43-2022]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts, Notification 
of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (Shingles 
and Flu Vaccines), Andover, Massachusetts

    Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of 
proposed production activity to the FTZ Board (the Board) for its 
facility in Andover, Massachusetts within Subzone 27R. The notification 
conforming to the requirements of the Board's regulations (15 CFR 
400.22) was received on September 8, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz. The proposed finished 
product(s) and material(s)/component(s) would be added to the 
production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed finished products include mRNA Varicella-Zoster Virus 
Shingles Vaccine and saRNA Flu Vaccine (duty-free).
    The proposed foreign-status material/component is N1-Methyl-
Pseudouridine-5'-Triphosphate (duty rate, 6.5%). The request indicates 
that the material/component is subject to duties under Section 301 of 
the Trade Act of 1974 (section 301), depending on the country of 
origin. The applicable Section 301 decisions require subject 
merchandise to be admitted to FTZs in privileged foreign status (19 CFR 
146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is October 26, 
2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: September 12, 2022.
Christopher Kemp,
Acting Executive Secretary.
[FR Doc. 2022-20048 Filed 9-15-22; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.